142
Participants
Start Date
January 31, 2017
Primary Completion Date
June 19, 2024
Study Completion Date
June 19, 2024
Conjugated Estrogens/Bazedoxifene
Given PO
Laboratory Biomarker Analysis
Correlative studies
Pharmacological Study
Correlative studies
Placebo
Given PO
Quality-of-Life Assessment
Ancillary studies
Questionnaire Administration
Ancillary studies
University of Pittsburg/ Magee-Womens Hospital, Pittsburgh
Thomas Jefferson University, Philadelphia
John's Hopkins University, Baltimore
Northwestern University, Lake Forest
Northwestern Medicine - Delnor/Warrenville Cancer Centers/Central DuPage Hospital, Geneva
Northwestern University, Chicago
Washington University in St. Louis/ Siteman Cancer Center, St Louis
University of Colorado at Denver/ Department of Surgery, Aurora
Huntsman Cancer Institute, Salt Lake City
Dana Farber/Partners Cancer Care Inc, Boston
Collaborators (1)
National Cancer Institute (NCI)
NIH
Pfizer
INDUSTRY
University of Chicago - Department for Cancer Research
UNKNOWN
University of California, San Francisco
OTHER
Northwestern University
OTHER